- Sort by:
- Browse by:
- Permission not
granted for presentation
Invited Speaker
Helen M. Piwnica-Worms
UT MD Anderson Cancer Center, Houston, TX, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Xiaodong Wang
National Inst. of Biological Sciences, Beijing, China
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Sharon E. Plon
Baylor College of Medicine, Houston, TX, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Temitope O. Keku
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
- Free
- audio + slides
- Some slides withheld
Invited Speaker
Valerie M. Weaver
UCSF Medical Center, San Francisco, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
Kwok-Kin Wong
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Invited Speaker
José Baselga
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
Chairperson
Robert H. Vonderheide
Abramson Cancer Center of University of Pennsylvania, Philadelphia, PA, United States
- Permission not
granted for presentation
Engineering Improved Cancer Vaccines
Glenn Dranoff
Novartis Institutes for BioMedical Research, Cambridge, MA, United States
- Permission not
granted for presentation
Leukocytes as targets for therapy in solid tumors
Lisa M. Coussens
OHSU Knight Cancer Institute, Portland, OR, United States
- Free
- slides video
- audio + slides
- All slides included
Fatal Attraction: A new story featuring the immune system and pancreatic cancer
Elizabeth M. Jaffee
Johns Hopkins University, Baltimore, MD, United States
- Free
- audio only
- Audio only
The mechanistic basis of cancer immunotherapy
Ira Mellman
Genentech, Inc., South San Francisco, CA, United States
- Permission not
granted for presentation
Mouse models and cell of origin for Barrett's Esophagus
Timothy C. Wang
Columbia University Medical Center, New York, NY, United States
- Free
- audio only
- Audio only
Using 3D organoid culture systems to model the inflammatory microenvironment in Barrett's Esophagus
John P Lynch
Univ. of Pennsylvania, Philadelphia, PA, United States
- Permission not
granted for presentation
Functional genomics of Barrett's Esophagus and Esophageal Adenocarcinoma
Adam J. Bass
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- audio + slides
- Some slides withheld
Insights from the genetics of familial Barrett's Esophagus
Amitabh Chak
Case Western Reserve Univ., Cleveland, OH, United States
- Free
- slides video
- audio + slides
- All slides included
Introduction
Alberto Bardelli
IRCC - University of Turin, Medical School, Candiolo, Italy
- Free
- audio only
- Audio only
Consensus on CRC subclassification, biological interpretation and clinical applications
Sabine Tejpar
Catholic Univ. of Leuven, Leuven, Belgium
- Free
- audio + slides
- Some slides withheld
Colorectal cancer subtyping: from human tumors to preclinical models and back
Enzo Medico
IRC@C, University of Torino, Candiolo, Italy
- Free
- slides video
- audio + slides
- All slides included
Molecular subtypes of colon cancer and immune reaction
Pierre Laurent-Puig
Univ. of Paris V René Descartes, Paris, France
- Free
- slides video
- audio + slides
- All slides included
An Overview of Overdiagnosis
Edward F. Patz
Duke Univ. Medical Ctr., Durham, NC, United States
- Free
- slides video
- audio + slides
- All slides included
Lung Cancer Screening: Early Detection and Overdiagnosis
Denise R Aberle
UCLA David Geffen School of Medicine, Los Angeles, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Breast cancer screening: Early Detection and Overdiagnosis
Otis W. Brawley
American Cancer Society, Atlanta, GA, United States
- Free
- slides video
- audio + slides
- All slides included
Targeting immune checkpoints in cancer therapy: New insights and opportunities
James P. Allison
UT MD Anderson Cancer Center, Houston, TX, United States
- Free
- audio + slides
- Some slides withheld
Tapping the potential of immunogenic modulation to attack malignant cells that survive therapy
James W Hodge
National Cancer Inst., Bethesda, MD, United States